The fate of incomplete scaffold apposition of everolimus-eluting bioresorble scaffolds: A serial optical coherence tomography analysis
Abstract Background Incomplete stent apposition (ISA) can be divided into acute and late forms. Late ISA may be due to persistent ISA or late-acquired ISA (LAISA). This study evaluated the natural course of ISA after bioresorbable vascular scaffold (BRS) implantation using optical coherence tomograp...
Gespeichert in:
Veröffentlicht in: | Journal of cardiology 2017-11, Vol.70 (5), p.454-460 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 460 |
---|---|
container_issue | 5 |
container_start_page | 454 |
container_title | Journal of cardiology |
container_volume | 70 |
creator | Sato, Takao, MD Tölg, Ralph, MD El-Mawardy, Mohamed, MD Sulimov, Dmitriy S., MD Richardt, Gert, MD Abdel-Wahab, Mohamed, MD, FESC |
description | Abstract Background Incomplete stent apposition (ISA) can be divided into acute and late forms. Late ISA may be due to persistent ISA or late-acquired ISA (LAISA). This study evaluated the natural course of ISA after bioresorbable vascular scaffold (BRS) implantation using optical coherence tomography (OCT). Methods Thirty-two patients (45 BRS) were assessed immediately after BRS implantation and 1 year thereafter using OCT. Acute ISA identified after BRS implantation but absent at follow-up was defined as resolved; otherwise, it was considered persistent. LAISA was defined as newly developed ISA that was identified at follow-up despite complete apposition immediately after BRS implantation. Intra-BRS fibrin-like material (IBF) was identified as an irregular intraluminal mass. ISA percentage was expressed as follows: (number of ISA/total number of BRS struts) × 100. Results Among 45 BRS and 15,894 analyzed BRS struts, 34 and 882 had acute ISA post-procedure, respectively. At follow-up, 92 of 15,364 analyzed struts exhibited late ISA (64 persistent ISA and 28 LAISA). In 15 of 28 struts with LAISA, LAISA occurred at the sites adjacent to post-interventional dissection. Uncovered struts were more frequently observed in late ISA compared to apposed struts (3.7 ± 4.8 vs. 0.58 ± 2.2%, p = 0.09). IBF was significantly more common in BRS with late ISA (62.5 vs. 8.1%, p = 0.02). Receiver-operating characteristic curve analysis identified a cut-off value of 280 μm for acute ISA distance predicting persistent ISA. Conclusion Resolution of acute ISA after BRS is common. The occurrence of LAISA may be infrequent and may be a nidus of stent thrombosis. |
doi_str_mv | 10.1016/j.jjcc.2017.03.007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1896037742</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0914508717300941</els_id><sourcerecordid>1896037742</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-709d3c91e1bf70f9a13206c8ec90146bcaac85042aeff2e85767696499fcf4c83</originalsourceid><addsrcrecordid>eNp9ksGK1TAUhoMoznX0BVxIl25aT5rcpBERhmGcEQZcOK5Dmp7MTU2bmrQD9wV8blvuqODC1eHA9_9wPg4hrylUFKh411d9b21VA5UVsApAPiE72khRcsmap2QHivJyD408Iy9y7gEEqEY8J2d1w6UQbL8jP-8OWDgzYxFd4UcbhyngumVrnIuhK8w0xexnH8eNwAdMMfhhySWGZfbjfdH6mDDH1Ia_qfy-uCgyJm9CEafZ23XaeMCEo8VijkO8T2Y6HAszmnDMPr8kz5wJGV89znPy7dPV3eVNefvl-vPlxW1puVRzKUF1zCqKtHUSnDKU1SBsg1YB5aK1xthmD7w26FyNzV4KKZTgSjnruG3YOXl76p1S_LFgnvXgs8UQzIhxyZo2SgCTktcrWp9Qm2LOCZ2ekh9MOmoKevOve73515t_DUyv_tfQm8f-pR2w-xP5LXwFPpwAXK988Jh0tn6z0vmEdtZd9P_v__hP3AY_bn6_4xFzH5e0Gl3v0LnWoL9uH7A9AJUMQHHKfgEIC662</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1896037742</pqid></control><display><type>article</type><title>The fate of incomplete scaffold apposition of everolimus-eluting bioresorble scaffolds: A serial optical coherence tomography analysis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Sato, Takao, MD ; Tölg, Ralph, MD ; El-Mawardy, Mohamed, MD ; Sulimov, Dmitriy S., MD ; Richardt, Gert, MD ; Abdel-Wahab, Mohamed, MD, FESC</creator><creatorcontrib>Sato, Takao, MD ; Tölg, Ralph, MD ; El-Mawardy, Mohamed, MD ; Sulimov, Dmitriy S., MD ; Richardt, Gert, MD ; Abdel-Wahab, Mohamed, MD, FESC</creatorcontrib><description>Abstract Background Incomplete stent apposition (ISA) can be divided into acute and late forms. Late ISA may be due to persistent ISA or late-acquired ISA (LAISA). This study evaluated the natural course of ISA after bioresorbable vascular scaffold (BRS) implantation using optical coherence tomography (OCT). Methods Thirty-two patients (45 BRS) were assessed immediately after BRS implantation and 1 year thereafter using OCT. Acute ISA identified after BRS implantation but absent at follow-up was defined as resolved; otherwise, it was considered persistent. LAISA was defined as newly developed ISA that was identified at follow-up despite complete apposition immediately after BRS implantation. Intra-BRS fibrin-like material (IBF) was identified as an irregular intraluminal mass. ISA percentage was expressed as follows: (number of ISA/total number of BRS struts) × 100. Results Among 45 BRS and 15,894 analyzed BRS struts, 34 and 882 had acute ISA post-procedure, respectively. At follow-up, 92 of 15,364 analyzed struts exhibited late ISA (64 persistent ISA and 28 LAISA). In 15 of 28 struts with LAISA, LAISA occurred at the sites adjacent to post-interventional dissection. Uncovered struts were more frequently observed in late ISA compared to apposed struts (3.7 ± 4.8 vs. 0.58 ± 2.2%, p = 0.09). IBF was significantly more common in BRS with late ISA (62.5 vs. 8.1%, p = 0.02). Receiver-operating characteristic curve analysis identified a cut-off value of 280 μm for acute ISA distance predicting persistent ISA. Conclusion Resolution of acute ISA after BRS is common. The occurrence of LAISA may be infrequent and may be a nidus of stent thrombosis.</description><identifier>ISSN: 0914-5087</identifier><identifier>EISSN: 1876-4738</identifier><identifier>DOI: 10.1016/j.jjcc.2017.03.007</identifier><identifier>PMID: 28476635</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Aged ; Bioresorbable scaffolds ; Cardiovascular ; Drug-Eluting Stents - adverse effects ; Everolimus - administration & dosage ; Female ; Humans ; Malapposition ; Male ; Middle Aged ; Optical coherence tomography ; Thrombosis ; Tomography, Optical Coherence - methods</subject><ispartof>Journal of cardiology, 2017-11, Vol.70 (5), p.454-460</ispartof><rights>Japanese College of Cardiology</rights><rights>2017 Japanese College of Cardiology</rights><rights>Copyright © 2017 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c479t-709d3c91e1bf70f9a13206c8ec90146bcaac85042aeff2e85767696499fcf4c83</citedby><cites>FETCH-LOGICAL-c479t-709d3c91e1bf70f9a13206c8ec90146bcaac85042aeff2e85767696499fcf4c83</cites><orcidid>0000-0002-9606-3246</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jjcc.2017.03.007$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28476635$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sato, Takao, MD</creatorcontrib><creatorcontrib>Tölg, Ralph, MD</creatorcontrib><creatorcontrib>El-Mawardy, Mohamed, MD</creatorcontrib><creatorcontrib>Sulimov, Dmitriy S., MD</creatorcontrib><creatorcontrib>Richardt, Gert, MD</creatorcontrib><creatorcontrib>Abdel-Wahab, Mohamed, MD, FESC</creatorcontrib><title>The fate of incomplete scaffold apposition of everolimus-eluting bioresorble scaffolds: A serial optical coherence tomography analysis</title><title>Journal of cardiology</title><addtitle>J Cardiol</addtitle><description>Abstract Background Incomplete stent apposition (ISA) can be divided into acute and late forms. Late ISA may be due to persistent ISA or late-acquired ISA (LAISA). This study evaluated the natural course of ISA after bioresorbable vascular scaffold (BRS) implantation using optical coherence tomography (OCT). Methods Thirty-two patients (45 BRS) were assessed immediately after BRS implantation and 1 year thereafter using OCT. Acute ISA identified after BRS implantation but absent at follow-up was defined as resolved; otherwise, it was considered persistent. LAISA was defined as newly developed ISA that was identified at follow-up despite complete apposition immediately after BRS implantation. Intra-BRS fibrin-like material (IBF) was identified as an irregular intraluminal mass. ISA percentage was expressed as follows: (number of ISA/total number of BRS struts) × 100. Results Among 45 BRS and 15,894 analyzed BRS struts, 34 and 882 had acute ISA post-procedure, respectively. At follow-up, 92 of 15,364 analyzed struts exhibited late ISA (64 persistent ISA and 28 LAISA). In 15 of 28 struts with LAISA, LAISA occurred at the sites adjacent to post-interventional dissection. Uncovered struts were more frequently observed in late ISA compared to apposed struts (3.7 ± 4.8 vs. 0.58 ± 2.2%, p = 0.09). IBF was significantly more common in BRS with late ISA (62.5 vs. 8.1%, p = 0.02). Receiver-operating characteristic curve analysis identified a cut-off value of 280 μm for acute ISA distance predicting persistent ISA. Conclusion Resolution of acute ISA after BRS is common. The occurrence of LAISA may be infrequent and may be a nidus of stent thrombosis.</description><subject>Aged</subject><subject>Bioresorbable scaffolds</subject><subject>Cardiovascular</subject><subject>Drug-Eluting Stents - adverse effects</subject><subject>Everolimus - administration & dosage</subject><subject>Female</subject><subject>Humans</subject><subject>Malapposition</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Optical coherence tomography</subject><subject>Thrombosis</subject><subject>Tomography, Optical Coherence - methods</subject><issn>0914-5087</issn><issn>1876-4738</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9ksGK1TAUhoMoznX0BVxIl25aT5rcpBERhmGcEQZcOK5Dmp7MTU2bmrQD9wV8blvuqODC1eHA9_9wPg4hrylUFKh411d9b21VA5UVsApAPiE72khRcsmap2QHivJyD408Iy9y7gEEqEY8J2d1w6UQbL8jP-8OWDgzYxFd4UcbhyngumVrnIuhK8w0xexnH8eNwAdMMfhhySWGZfbjfdH6mDDH1Ia_qfy-uCgyJm9CEafZ23XaeMCEo8VijkO8T2Y6HAszmnDMPr8kz5wJGV89znPy7dPV3eVNefvl-vPlxW1puVRzKUF1zCqKtHUSnDKU1SBsg1YB5aK1xthmD7w26FyNzV4KKZTgSjnruG3YOXl76p1S_LFgnvXgs8UQzIhxyZo2SgCTktcrWp9Qm2LOCZ2ekh9MOmoKevOve73515t_DUyv_tfQm8f-pR2w-xP5LXwFPpwAXK988Jh0tn6z0vmEdtZd9P_v__hP3AY_bn6_4xFzH5e0Gl3v0LnWoL9uH7A9AJUMQHHKfgEIC662</recordid><startdate>20171101</startdate><enddate>20171101</enddate><creator>Sato, Takao, MD</creator><creator>Tölg, Ralph, MD</creator><creator>El-Mawardy, Mohamed, MD</creator><creator>Sulimov, Dmitriy S., MD</creator><creator>Richardt, Gert, MD</creator><creator>Abdel-Wahab, Mohamed, MD, FESC</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9606-3246</orcidid></search><sort><creationdate>20171101</creationdate><title>The fate of incomplete scaffold apposition of everolimus-eluting bioresorble scaffolds: A serial optical coherence tomography analysis</title><author>Sato, Takao, MD ; Tölg, Ralph, MD ; El-Mawardy, Mohamed, MD ; Sulimov, Dmitriy S., MD ; Richardt, Gert, MD ; Abdel-Wahab, Mohamed, MD, FESC</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-709d3c91e1bf70f9a13206c8ec90146bcaac85042aeff2e85767696499fcf4c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Bioresorbable scaffolds</topic><topic>Cardiovascular</topic><topic>Drug-Eluting Stents - adverse effects</topic><topic>Everolimus - administration & dosage</topic><topic>Female</topic><topic>Humans</topic><topic>Malapposition</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Optical coherence tomography</topic><topic>Thrombosis</topic><topic>Tomography, Optical Coherence - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sato, Takao, MD</creatorcontrib><creatorcontrib>Tölg, Ralph, MD</creatorcontrib><creatorcontrib>El-Mawardy, Mohamed, MD</creatorcontrib><creatorcontrib>Sulimov, Dmitriy S., MD</creatorcontrib><creatorcontrib>Richardt, Gert, MD</creatorcontrib><creatorcontrib>Abdel-Wahab, Mohamed, MD, FESC</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sato, Takao, MD</au><au>Tölg, Ralph, MD</au><au>El-Mawardy, Mohamed, MD</au><au>Sulimov, Dmitriy S., MD</au><au>Richardt, Gert, MD</au><au>Abdel-Wahab, Mohamed, MD, FESC</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The fate of incomplete scaffold apposition of everolimus-eluting bioresorble scaffolds: A serial optical coherence tomography analysis</atitle><jtitle>Journal of cardiology</jtitle><addtitle>J Cardiol</addtitle><date>2017-11-01</date><risdate>2017</risdate><volume>70</volume><issue>5</issue><spage>454</spage><epage>460</epage><pages>454-460</pages><issn>0914-5087</issn><eissn>1876-4738</eissn><abstract>Abstract Background Incomplete stent apposition (ISA) can be divided into acute and late forms. Late ISA may be due to persistent ISA or late-acquired ISA (LAISA). This study evaluated the natural course of ISA after bioresorbable vascular scaffold (BRS) implantation using optical coherence tomography (OCT). Methods Thirty-two patients (45 BRS) were assessed immediately after BRS implantation and 1 year thereafter using OCT. Acute ISA identified after BRS implantation but absent at follow-up was defined as resolved; otherwise, it was considered persistent. LAISA was defined as newly developed ISA that was identified at follow-up despite complete apposition immediately after BRS implantation. Intra-BRS fibrin-like material (IBF) was identified as an irregular intraluminal mass. ISA percentage was expressed as follows: (number of ISA/total number of BRS struts) × 100. Results Among 45 BRS and 15,894 analyzed BRS struts, 34 and 882 had acute ISA post-procedure, respectively. At follow-up, 92 of 15,364 analyzed struts exhibited late ISA (64 persistent ISA and 28 LAISA). In 15 of 28 struts with LAISA, LAISA occurred at the sites adjacent to post-interventional dissection. Uncovered struts were more frequently observed in late ISA compared to apposed struts (3.7 ± 4.8 vs. 0.58 ± 2.2%, p = 0.09). IBF was significantly more common in BRS with late ISA (62.5 vs. 8.1%, p = 0.02). Receiver-operating characteristic curve analysis identified a cut-off value of 280 μm for acute ISA distance predicting persistent ISA. Conclusion Resolution of acute ISA after BRS is common. The occurrence of LAISA may be infrequent and may be a nidus of stent thrombosis.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>28476635</pmid><doi>10.1016/j.jjcc.2017.03.007</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-9606-3246</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0914-5087 |
ispartof | Journal of cardiology, 2017-11, Vol.70 (5), p.454-460 |
issn | 0914-5087 1876-4738 |
language | eng |
recordid | cdi_proquest_miscellaneous_1896037742 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Aged Bioresorbable scaffolds Cardiovascular Drug-Eluting Stents - adverse effects Everolimus - administration & dosage Female Humans Malapposition Male Middle Aged Optical coherence tomography Thrombosis Tomography, Optical Coherence - methods |
title | The fate of incomplete scaffold apposition of everolimus-eluting bioresorble scaffolds: A serial optical coherence tomography analysis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T21%3A47%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20fate%20of%20incomplete%20scaffold%20apposition%20of%20everolimus-eluting%20bioresorble%20scaffolds:%20A%20serial%20optical%20coherence%20tomography%20analysis&rft.jtitle=Journal%20of%20cardiology&rft.au=Sato,%20Takao,%20MD&rft.date=2017-11-01&rft.volume=70&rft.issue=5&rft.spage=454&rft.epage=460&rft.pages=454-460&rft.issn=0914-5087&rft.eissn=1876-4738&rft_id=info:doi/10.1016/j.jjcc.2017.03.007&rft_dat=%3Cproquest_cross%3E1896037742%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1896037742&rft_id=info:pmid/28476635&rft_els_id=1_s2_0_S0914508717300941&rfr_iscdi=true |